Journals / Ağrı / 2013 / Cilt: 25 - Sayı: 4

The effects of pregabaline on postoperative pain and opioid consumption used perioperatively in patients undergoing modified radical mastectomy

Modifiye radikal mastektomi ameliyatlarında perioperatif kullanılan pregabalinin ameliyat sonrası ağrı ve opioid tüketimi üzerine etkisi

Journal
Ağrı
Pages
169–178
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We think that further studies about this topic must be held with different dose and patient groups.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study, effects of pregabaline on postoperative pain and opioid consumption used perioperatively in patients under- going modified radical mastectomy(MRM) were investigated.
📊
Key Findings & Data:Methods: Sixty ASA 1-2 patients scheduled for MRM were included.
💡
Conclusion & Impact:We think that further studies about this topic must be held with different dose and patient groups.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: In this study, effects of pregabaline on postoperative pain and opioid consumption used perioperatively in patients under- going modified radical mastectomy(MRM) were investigated. Methods: Sixty ASA 1-2 patients scheduled for MRM were included. Patients were randomly divided into two and 30 patients were allocated into each group. Group Pregabaline was given pregabaline 150mg 1hr before operation and Group Placebo empty capsule. In both groups, anesthesia induction was obtained by penthotal, fentanyl and rocuronium and maintainence by sevoflurane, N2O and O2. Twelve hr after operation, Group Pregabaline was administered pregabaline 75mg while Placebo group received empty capsule again. All patients received lornoxicam 8mg iv 1hr before end of surgery and ondansetrone 4mg 30min before. Patient-controlled analgesia device prepared with morphine was connected to both groups for postoperative analgesia. Postoperative VAS pain scores, he- modynamic parameters, morphine consumption, side-effects like nausea-vomiting, sedation and dizziness were followed and recorded. Results: Demographic parameters were similar. VAS scores were significantly lower in Group Pregabaline at 1, 30min, 1,4,8 and 12hr (p<0.05). There was no significant difference in postoperative morphine consumption and need for additional dose, although they were higher in Placebo group. The patients in Placebo group had higher bothersome scores for side-effects. Hemodynamic param- eters and other side-effects were similar. Conclusion: In our study, we showed that pregabalin administered perioperatively increased postoperative analgesic efficacy in MRM operations without making significant side effect, but did not change opioid consumption. We think that further studies about this topic must be held with different dose and patient groups.

Özet

Amaç: Bu çalışmada, modifiye radikal mastektomi (MRM) ameliyatı uygulanan hastalarda perioperatif kullanılan pregabalinin ameliyat sonrası ağrı ve opioid tüketimi üzerine etkileri araştırıldı. Gereç ve Yöntem: Çalışmaya MRM ameliyatı planlanan ASA 1-2 60 kadın hasta dahil edildi. Hastalar rastgele ikiye ayrılarak her gruba 30’ar hasta alındı. Pregabalin grubuna ameliyattan bir saat önce 150 mg oral pregabalin, plasebo grubuna içi boş kapsül verildi. Anestezi indüksiyonu her iki grupta da pentotal, fentanil ve roküronyum, idame ise sevofluran, N2O ve O2 ile sağlandı. Ameliyattan 12 saat sonra pregabalin grubundaki hastalara 75 mg pregabalin verilirken, plasebo grubuna tekrar boş kapsül verildi. Tüm hastalara cerrahi bitiminden bir saat önce 8 mg iv lornoksikam, 30 dk önce 4 mg ondansetron yapıldı. Her iki gruba da ameliyat sonrası analjezi için morfinle hazırlanmış hasta kontrollü analjezi cihazı bağlandı. Ameliyat sonrası VAS ağrı skorları, hemodinamik parametreler, morfin tüketimi, bulantı, kusma, sedasyon ve baş dönmesi gibi yan etkiler takip edilerek kaydedildi. Bulgular: Demografik parametreler benzerdi. VAS ağrı skorları pregabalin grubunda birinci dk, 30. dk, bir, dört, sekiz ve 12 saatlerde anlamlı olarak düşüktü (p<0.05). Ameliyat sonrası morfin tüketimi ve ek doz gereksinimi plasebo grubunda daha fazla olmakla beraber iki grup arasında anlamlı farklılık yoktu. Placebo grubundaki hastalar daha yüksek yan etkilerden rahatsızlık skorlarına sahip bulundu. Hemodinamik parametreler ve diğer yan etkiler benzerdi. Sonuç: Çalışmamızda perioperatif uygulanan pregabalinin, MRM ameliyatlarında belirgin yan etki yapmadan ameliyat sonrası analjezinin etkinliğini artırdığını, fakat opioid tüketimini değiştirmediğini gördük. Bu konuda farklı doz ve hasta gruplarıyla daha ileri çalışmalar yapılması gerektiğini düşünüyoruz.

🔖

Cite This Article

KOYUNCU, T., OĞUZ, G., AKBEN, S., NAS, S., ÜNVER, S. (2013). The effects of pregabaline on postoperative pain and opioid consumption used perioperatively in patients undergoing modified radical mastectomy. Ağrı, Cilt: 25 - Sayı: 4, 169–178. https://ajindex.com/articles/163616

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Uyar M. Postoperatif ağrılı hastanın değerlendirilmesi ve ağrı ölçümü, postoperatif analjezi. Yücel A, editör. İstanbul: Ma- vimer Matbaacılık; 2004. s. 27-36
  2. Erdine S. Ağrı mekanizmaları. İçinde: Erdine S, editör. Ağrı. İstanbul: Nobel Matbaacılık; 2002. s. 20-9
  3. Peng PW, Wijeysundera DN, Li CC. Use of gabapentin for perioperative pain control-a meta-analysis. Pain Res Manag 2007;12(2):85-92
  4. Pyati S, Gan TJ. Perioperative pain management. CNS Drugs 2007;21(3):185-211
  5. Ceyhan D, Güleç MS. Is postoperative pain only a nociceptive pain?. Agri 2010;22(2):47-52
  6. Woolf CJ, Max MB. Mechanism-based pain diagnosis: is- sues for analgesic drug development. Anesthesiology 2001;95(1):241-9
  7. Carr DB, Goudas LC. Acute pain. Lancet 1999;353(9169):2051- 8
  8. Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006;67(10):1792-800
  9. Frampton JE, Scott LJ. Pregabalin: in the treatment of painful diabetic peripheral neuropathy. Drugs 2004;64(24):2813-21
  10. Frampton JE, Foster RH. Pregabalin: in the treatment of postherpetic neuralgia. Drugs 2005;65(1):111-20
  11. Mathiesen O, Møiniche S, Dahl JB. Gabapentin and postoper- ative pain: a qualitative and quantitative systematic review, with focus on procedure. BMC Anesthesiol 2007;7:6
  12. Agarwal A, Gautam S, Gupta D, Agarwal S, Singh PK, Singh U. Evaluation of a single preoperative dose of pregabalin for attenuation of postoperative pain after laparoscopic chole- cystectomy. Br J Anaesth 2008;101(5):700-4
  13. Jokela R, Ahonen J, Tallgren M, Haanpää M, Korttila K. A ran- domized controlled trial of perioperative administration of pregabalin for pain after laparoscopic hysterectomy. Pain 2008;134(1-2):106-12
  14. Mathiesen O, Jacobsen LS, Holm HE, Randall S, Adamiec- Malmstroem L, Graungaard BK, et al. Pregabalin and dexa- methasone for postoperative pain control: a random- ized controlled study in hip arthroplasty. Br J Anaesth 2008;101(4):535-41
  15. Mathiesen O, Rasmussen ML, Dierking G, Lech K, Hilsted KL, Fomsgaard JS, et al. Pregabalin and dexamethasone in com- bination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial. Acta Anaesthesiol Scand 2009;53(2):227-35
  16. Peng PW, Li C, Farcas E, Haley A, Wong W, Bender J, et al. Use of low-dose pregabalin in patients undergoing laparoscopic cholecystectomy. Br J Anaes